X Facebook LinkedIn WhatsApp Press Releases (-) Any 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Reset 2019 May 29, 2019 argenx to Present at Upcoming Investor Conferences May 27, 2019 argenx announces publication of efgartigimod Phase 2 myasthenia gravis trial results in Neurology May 21, 2019 argenx announces pipeline expansion and “argenx 2021” vision to build integrated immunology company at 2019 R&D Day May 14, 2019 argenx to Host R&D Day on May 22, 2019 May 8, 2019 argenx reports first quarter 2019 financial results and provides business update May 7, 2019 argenx to Present at Bank of America Merrill Lynch 2019 Health Care Conference May 6, 2019 argenx announces results of Annual General Meeting of Shareholders March 25, 2019 argenx announces Annual General Meeting of Shareholders on May 7, 2019 March 13, 2019 argenx to receive first clinical milestone payment for product candidate developed March 3, 2019 argenx to Present at Cowen and Company 39th Annual Health Care Conference February 27, 2019 argenx reports fourth quarter business update and full year 2018 financial results February 20, 2019 argenx to host conference call & webcast to report fourth quarter business update and full year 2018 financial results on February 28, 2019 Pagination First page « First Previous page ‹ Previous … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Next page Next › Last page Last »